SQUAWK/NEWS
Account
Theme
Account
Menu
Live News GEOPOLITICS FLASH H impact

Parabilis Medicines Reports Third Quarter 2026 Financial Results and Provides Business Updates

Presented updated Phase 1/2 data at ESMO Congress 2026 demonstrating a 72.2% objective response rate

PBLS

Related stories